Compare State Street SPDR S&P Biotech ETF (XBI) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs State Street Real Estate Select Sector SPDR ETF — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.5, while State Street Real Estate Select Sector SPDR ETF trades at $45.21. Which is the better fit depends on your goals.
| XBI | XLRE | |
|---|---|---|
Sector | Broad Market / Factor | Sector/Thematic |
52-Week High | $164.28 | $45.46 |
52-Week Low | $85.16 | $40.01 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
